Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 7,090 | 62 | 0 | 0 | 25,000 |
| Cost of Goods | 8 | N/A | N/A | N/A | N/A |
| Gross Profit | 7,082 | 62 | N/A | N/A | 25,000 |
| Operating Expenses | 76,022 | 75,324 | 70,373 | 58,353 | 47,975 |
| Operating Income | -68,932 | -75,262 | -70,373 | -58,353 | -22,975 |
| Interest Expense | 0 | 0 | 12 | 17 | 25 |
| Other Income | 1,691 | 2,455 | 3,169 | 2,174 | 1,540 |
| Pre-tax Income | -67,241 | -72,807 | -67,216 | -56,196 | -21,460 |
| Net Income Continuous | -67,241 | -72,807 | -67,216 | -56,196 | -21,460 |
| Net Income | $-67,241 | $-72,807 | $-67,216 | $-56,196 | $-21,460 |
| EPS Basic Total Ops | -1.20 | -1.36 | -1.39 | -1.28 | -0.56 |
| EPS Basic Continuous Ops | -1.20 | -1.36 | -1.40 | -1.28 | -0.56 |
| EPS Diluted Total Ops | -1.20 | -1.36 | -1.39 | -1.28 | -0.56 |
| EPS Diluted Continuous Ops | -1.20 | -1.36 | -1.40 | -1.28 | -0.56 |
| EBITDA(a) | $-68,448 | $-74,802 | $-69,928 | $-58,184 | $-22,863 |